Experimental Analysis of the Efficacy of Dihydroquercetin on the Model of Chronic Nonbacterial Inflammation of the Prostatic Gland
- 作者: Borovskaya T.1, Kamalova S.1, Polyektova M.1, Mashanova V.1, Vychuzhanina A.1, Kseneva S.1, Plotnikov M.1, Goldberg V.2
-
隶属关系:
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
- Tomsk Research Institute of Oncology, Tomsk National Medical Research Center
- 期: 卷 164, 编号 5 (2018)
- 页面: 617-619
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239788
- DOI: https://doi.org/10.1007/s10517-018-4044-7
- ID: 239788
如何引用文章
详细
We studied the efficiency of dihydroquercetin on the model of chronic nonbacterial inflammation of the prostatic gland in rats. It was found that administration of dihydroquercetin was followed by a significant decrease in the area of the connective tissue in the prostatic gland to initial levels, which attested to antifibrotic properties of this oxidant. Additionally, the substance prevented the development of atrophy of acinus epithelium. After administration of reference drug Prostamol Uno, only moderate antifibrotic effects were observed.
作者简介
T. Borovskaya
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
编辑信件的主要联系方式.
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
S. Kamalova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
M. Polyektova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
V. Mashanova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
A. Vychuzhanina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
S. Kseneva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
M. Plotnikov
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences
Email: repropharm@yandex.ru
俄罗斯联邦, Moscow
V. Goldberg
Tomsk Research Institute of Oncology, Tomsk National Medical Research Center
Email: repropharm@yandex.ru
俄罗斯联邦, Tomsk